Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
Clinical trial NCT04048343 · COMPLETED
Trial details
- NCT number
- NCT04048343
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2021-03-18
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.